KROS
Ticker
Keros Therapeutics, Inc.
KROSKROS has 3 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 0 purchases and 3 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Feb 19 and filed Feb 20. The most active filer was ADAR1 Partners, LP with 1 filing.
Add to watchlistFilings, ttm
3
0 buys · 3 sells
Traders, ttm
3
3 insiders
Volume, ttmiDollar value disclosed in the window
$180.7M
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Feb 19
Filed Feb 20
ADViAverage daily dollar volume
–
not on file
Share price · 12M
$10.28 (-35.3%)
Adjusted for splits and dividends.
Volume by month
Buys $9.5M
Sells $182.6M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
AL
ADAR1 Partners, LP
10% owner
1 filing
TK
Tomer Kariv
Director
1 filing
KR
Keith Regnante
CHIEF FINANCIAL OFFICER
1 filing
DS
Daniel Schneeberger
10% owner
1 filing
JS
Jasbir Seehra
CHIEF EXECUTIVE OFFICER
1 filing
Recent filings
Jasbir SeehraSALE
CHIEF EXECUTIVE OFFICER
$113K7,015 sh × $16.17
Exec Feb 19
Filed Feb 20 · 5:30 PM ET Tomer KarivSALE Director $85.0M
4,787,331 sh across 4 lots
Exec Oct 15 2025
Filed Oct 17 2025 · 5:30 PM ET Daniel SchneebergerSALE 10% owner $95.7M
5,389,264 sh across 3 lots
Exec Oct 15 2025
Filed Oct 15 2025 · 5:30 PM ET ADAR1 Partners, LPPURCHASE 10% owner $9.5M
934,258 sh across 5 lots
Exec Apr 9 2025
Filed Apr 11 2025 · 5:30 PM ET Keith RegnanteSALE CHIEF FINANCIAL OFFICER $1.8M
40,000 sh × $45.29
Exec Jan 4 2024
Filed Jan 24 2025 · 5:30 PM ET †